InvestorsHub Logo
Post# of 252331
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: AlpineBV_Miller post# 97057

Thursday, 06/10/2010 12:02:00 PM

Thursday, June 10, 2010 12:02:00 PM

Post# of 252331
Back to your original subject, I believe it depends on the data from the phase III in 1st line study where HLA-A*0201+ was not an inclusion criteria, and whether this study will be required for approval.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.